World Wide Relics Changes Majority Ownership and Takes on New Management
NEW YORK, June 21 /PRNewswire/ -- World Wide Relics, Inc. (OTC Bulletin Board: WRLC) ("WWR"), announced today that its majority ownership has been acquired by China PharmaHub Corp. ("PharmaHub"). PharmaHub is a global pharmaceutical HUB specializing in the identification, development and marketing of pharmaceutical and healthcare products.
In conjunction with the purchase, Mr. John Amand and Mr. E. Todd Owens have resigned as officers and directors of the board. Mr. Richard Lui and Ms. Monica Ding have been appointed to the board of directors and Mr. Lui will assume the role of Chairman and Chief Executive Officer of WWR effective immediately.
About World Wide Relics:
World Wide Relics, Inc. produces and markets historical costumes and reenactment clothing lines. The company sells its products to the enthusiasts and collectors on e-stores, such as Ebay.com. World Wide Relics, Inc. was founded in 2005 and is based in New York, New York. As of January 17, 2007, World Wide Relics, Inc. operates as a subsidiary of Electric Car Company, Inc.
China PharmaHub Corp. is engaged in the business of licensing, development and commercialization of pharmaceutical and healthcare products and technologies between Chinese pharmaceutical companies and other pharmaceutical companies located worldwide with initial emphasis in the United States and Europe (with a goal of eventually becoming a global pharmaceutical "HUB"). PharmaHub brings a unique wealth of resources to assist scientists and companies in bringing their ideas to reality. PharmaHub's corporate headquarters are located in California, with offices in Boston and China.
This press release, together with other statements and information publicly disseminated by the Company, contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The Company intends such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and includes this statement for purposes of complying with these safe harbor provisions. Forward-looking statements, which are based on certain assumptions and describe the Company's future plans, strategies and expectations, are generally identifiable by use of the words "believe," "expect," "intend," "anticipate," "estimate," "project" or similar expressions. You should not rely on forward-looking statements since they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond the Company's control and which could materially affect actual results, performances or achievements. Factors that may cause actual results to differ materially from current expectations include the risk factors discussed in the Company's filing with the Securities Exchange Commission. Accordingly, there is no assurance that the Company's expectations will be realized. Except as otherwise required by the federal securities laws, the Company disclaims any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.
SOURCE China PharmaHub Corp.